Bosh sahifa4142 • TPE
add
Adimmune Corp
Yopilish kursi
17,75 $
Kunlik diapazon
17,35 $ - 17,70 $
Yillik diapazon
15,90 $ - 22,60 $
Bozor kapitalizatsiyasi
7,45 mlrd TWD
Oʻrtacha hajm
2,49 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TPE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (TWD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 475,32 mln | -46,49% |
Joriy xarajat | 146,27 mln | -14,74% |
Sof foyda | -18,26 mln | -106,93% |
Sof foyda marjasi | -3,84 | -112,96% |
Har bir ulushga tushum | — | — |
EBITDA | -19,68 mln | -106,24% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (TWD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,79 mlrd | -3,29% |
Jami aktivlari | 8,38 mlrd | -2,80% |
Jami passivlari | 3,53 mlrd | 18,40% |
Umumiy kapital | 4,85 mlrd | — |
Tarqatilgan aksiyalar | 421,51 mln | — |
Narxi/balansdagi bahosi | 1,58 | — |
Aktivlardan daromad | -1,86% | — |
Kapitaldan daromad | -1,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (TWD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -18,26 mln | -106,93% |
Operatsiyalardan naqd pul | -355,08 mln | -17,80% |
Sarmoyadan naqd pul | -173,61 mln | -102,13% |
Moliyadan naqd pul | 403,21 mln | 5 593,35% |
Naqd pulning sof oʻzgarishi | -117,89 mln | 70,35% |
Boʻsh pul | -460,83 mln | -29,17% |
Haqida
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Tashkil etilgan
1965
Sayt
Xodimlar soni
564
